COMPOSITION FOR POLYAMINE BIOSYNTHESIS

Lasofoxifene treatment of breast cancer

NOVEL USE OF A MODULATOR OF GLUCOSYLCERAMIDE DEGRADATION FOR VIRAL INFECTIONS

DOSAGE REGIME WITH ESKETAMINE FOR TREATING MAJOR DEPRESSIVE DISORDER

Pharmacological prophylactics against stress-induced affective disorders in females

COMPOUND AND METHOD FOR THE TREATMENT OF CORONAVIRUSES

COMPOSITIONS COMPRISING THYMOL FOR USE IN THE TREATMENT OF INFLAMMATORY OR FUNCTIONAL BOWEL DISORDERS BY MODULATING THE ENDOCANNABINOID SYSTEM

Methods of permeabilizing the blood brain barrier

SYNERGISTIC ANTI-VIRAL PHARMACEUTICAL COMPOSITION CONTAINING TARGETING NANOPARTICLES

COMPOSITIONS AND METHODS FOR TREATING CORONAVIRUS

Method for Prohibiting and/or Treating an Eye Condition

COMPOSITIONS AND METHODS FOR INHIBITING HAIR GROWTH

Methods of diagnosing and treating lung cancer

FMRP AND CANCER TREATMENT

TREATMENT OF FOOD ALLERGY USING ANTI-IGE ANTIBODIES

TUMOR SELECTIVE MACROPINOCYTOSIS-DEPENDENT RAPIDLY INTERNALIZING ANTIBODIES

ANTI-CD73 ANTIBODIES AND COMPOSITIONS

AGONIST ANTI-CD40 ANTIBODIES

PDL2 compounds

Peptides for use in immunotherapy against cancers

SPAK/OSR INHIBITORS AND METHODS OF USING SAME

Phenethylamine compounds salts, polymorphic forms and methods of use thereof

COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING A SYMPTOM ASSOCIATED WITH GOUT OR HYPERURICEMIA

USP9X INHIBITORS

ADENO-ASSOCIATED VIRUS FOR THERAPEUTIC DELIVERY TO CENTRAL NERVOUS SYSTEM

Steroid acid-peptide based cytotoxic compounds

METHODS FOR THE USE OF A B7-H3 ANTIBODY-DRUG CONJUGATE ALONE OR IN COMBINATION

Ras inhibitors

METHODS AND COMPOSITIONS FOR INDUCING FERROPTOSIS IN VIVO

METHODS OF TREATING CANCER USING TIGIT INHIBITORS AND ANTI-CANCER AGENTS

ACTRII PROTEINS FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION (PAH)

Mutant Peptides And Methods Of Treating Subjects Using The Same

Topical antibiotic

PHARMACEUTICAL COMPOSITION COMPRISING A COMBINATION OF A GUANYLATE CYCLASE C (GUCY2C) AGONIST AND A SHORT-CHAIN FATTY ACID OR PRODRUG THEREOF

IONIC SELF-ASSEMBLING PEPTIDES

Synergistic bacterial compositions and methods of production and use thereof

METHODS AND COMPOSITIONS FOR TREATING CORONAVIRUS INFECTIOUS DISEASE

Injectable antibiotic formulations and use thereof

Treatments of prostate cancer

PHOSPHOLIPIDS AND PHOSPHOLIPID METABOLITES FOR TREATING VIRAL AND BACTERIAL PNEUMONIA AND SEPSIS

Methods of altering bone growth by administration of Sost or Wise antagonist or agonist

METHOD, SYSTEM, FORMULATION AND KIT FOR THE TREATMENT OF ONYCHOMYCOSIS

COMPOUNDS FOR THE TREATMENT OF VIRAL INFECTIONS

COMBINATION CANCER THERAPY WITH DYRK1 INHIBITORS AND INHIBITORS OF THE RAS-RAF-MEK-ERK (MAPK) PATHWAY

Use of co-enzyme antagonists to slow metabolism

Pyruvate kinase activators for use in treating blood disorders

Compositions and use of varenicline for treating dry eye

Compositions and use of varenicline for treating dry eye

Compositions and use of varenicline for treating dry eye

USE OF MASITINIB FOR THE TREATMENT OF CORONAVIRUS DISEASE 2019 (COVID-19)

COMPOUNDS FOR THE TREATMENT OF VIRAL INFECTIONS

COMBINATION THERAPY COMPRISING AN FGFR INHIBITOR AND A KRAS INHIBITOR

ORAL FORMULATIONS OF PYRROLIDINE DERIVATIVES

COMPOSITION AND METHOD FOR TREATING CANCER

NEW COMBINATION COMPRISING N-ACETYL-L-CYSTEINE AND ITS USE

Combination Verapamil and Mometasone Therapy for the treatment of Chronic Rhinosinusitis

DELAYED RELEASE SOFTGEL CAPSULES

FORMULATION COMPRISING DAPRODUSTAT

ZWITTERIONIC POLYMER PARTICLE COMPOSITIONS AND RELATED METHODS

PROCESS FOR PRODUCING VISIBLY CLEAR AQUEOUS CONSUMABLE PRODUCTS

THERAPEUTIC, DIAGNOSTIC, AND PROGNOSTIC METHODS FOR CANCER

IRON-SCORE AND IN VITRO METHOD FOR IDENTIFYING HIGH RISK DLBCL SUBJECTS AND THERAPEUTIC USES AND METHODS

METHOD OF DIAGNOSING MITOCHONDRIAL DNA DISORDERS USING STOOL SAMPLES

THERAPEUTIC DRUG FOR POLYCYTHEMIA

Trispecific binding proteins, methods, and uses thereof

COMBINATIONAL USE OF AN ANTI-ILT3 ANTIBODY AND AN ANTI-LAIR-1 ANTIBODY

Methods of treatment of diseases in which IL-13 activity is detrimental using anti-IL-13 antibodies

NOVEL USE

ENGINEERED IL-12 AND IL-23 POLYPEPTIDES AND USES THEREOF

ANTHELMINTIC AZA-BENZOTHIOPHENE AND AZA-BENZOFURAN COMPOUNDS

PYRIMIDIN-4(3H)-ONE HETEROCYCLIC COMPOUND, PREPARATION METHOD THEREOF, AND PHARMACEUTICAL USE THEREOF

FUSED HETEROARYL HYDROXAMATES AS STING AGONISTS

Substituted carboxamides as inhibitors of WDR5 protein-protein binding

CARBOXY DERIVATIVES WITH ANTIINFLAMATORY PROPERTIES

Complex salt of rupestonic acid and alkaloid, preparation method therefor and use thereof

TREATMENT OF PSYCHIATRIC CONDITIONS SUCH AS RESISTANT DEPRESSION, BIPOLAR DISORDER AND/OR MAJOR DEPRESSIVE DISORDER VIA APPLICATION OF REPETITIVE TRANSCRANIAL MAGNETIC STIMULATION WITH THYROID HORMONE TREATMENT AND/OR QUETIAPINE

COGNITIVE FUNCTION WITHIN A HUMAN BRAIN

METHODS FOR TRIGGERING M1 MACROPHAGE POLARIZATION

METHOD OF PREVENTING AND TREATING TYPE 1 DIABETES, ALLOGRAFT REJECTION AND LUNG FIBROSIS (BY TARGETING THE ATP/P2X7R AXIS)

ALBUMIN DRUG CONJUGATES AND USE THEREOF FOR THE TREATMENT OF CANCER

Pharmaceutical compositions comprising meloxicam

AUGMENTATION OF FIBROBLAST THERAPY USING EXTRACORPOREAL SHOCK WAVE THERAPY AND/OR TRANSFECTION OF BIOLOGICALLY RELEVANT MOLECULES

TREATMENT WITH ANTI-VEGF ANTIBODIES

MIXED ALLERGEN COMPOSITIONS AND METHODS FOR USING THE SAME

Administration of CEBP-Beta Antagonist and Methods of Use

COMPOSITION AND METHOD FOR OMEGA-3 AND PLANT FLAVONOIDS FOR INCREASING HDL CHOLESTEROL AND DECREASING LDL CHOLESTEROL AND TRIGLYCERIDE LEVELS

Therapeutic material with low pH and low toxicity active against at least one pathogen for addressing patients with respiratory illnesses

COMPOSITIONS AND METHODS FOR TREATING A SARS-COV-2 INFECTION

ISOTONIC OR HYPERTONIC SALT-BASED COMPOSITIONS, TREATMENTS, DEVICES, AND ARTICLES FOR DELIVERY OF SAME TO LARYNX

CANCER TREATMENTS

PTEN inhibitors for treatment and prevention of bone marrow loss

Bortezomib compositions

NEUROACTIVE COMPOUNDS AND METHODS OF USE THEREOF

METHODS OF TREATING CASTRATION-RESISTANT PROSTATE CANCER WITH GLUCOCORTICOID RECEPTOR ANTAGONISTS AND ANTI-ANDROGEN RECEPTOR THERAPY AND ANTI-ANDROGEN RECEPTOR THERAPY

METHODS OF TREATING ORAL MUCOSITIS

SALTS OF NEUROCEUTICALS AND USES THEREOF

KILLING SENESCENT CELLS AND TREATING SENESCENCE-ASSOCIATED CONDITIONS USING A SRC INHIBITOR AND A FLAVONOID

COMPOUND FOR THE TREATMENT OF CORONAVIRAL INFECTIONS

ENHANCEMENT OF IMPAIRED MOTOR AND MENTAL FUNCTIONS, USING DEXTROMETHORPHAN AND OXIDASE ENZYME INHIBITOR

Analgesic formulations and methods for reduced postoperative nausea and vomiting and enhanced postoperative pain relief

Analgesic formulations and methods for reduced postoperative nausea and vomiting and enhanced postoperative pain relief

SUBSTITUTED PYRIDINES AND METHODS OF USE

METHODS INVOLVING NEUTROPHIL ELASTASE INHIBITOR ALVELESTAT FOR TREATING CORONAVIRUS INFECTION

COMBINATION THERAPY USING ENANTIOPURE, OXY-SUBSTITUTED, DEUTERIUM-ENRICHED 5-(BENZYL)-5-DEUTERO-THIAZOLIDINE-2,4-DIONES FOR TREATMENT OF MEDICAL DISORDERS

THERAPEUTIC COMPOUNDS, COMPOSITIONS, AND METHODS OF USE THEREOF

TREATMENT OF VIRAL INFECTIONS, OF ORGAN INJURY, AND OF RELATED CONDITIONS USING A HIF PROLYL HYDROXYLASE INHIBITOR OR A HIF-ALPHA STABILIZER

SYSTEMIC ISOXAZOLINE PARASITICIDES FOR VECTOR-BORNE AND VIRAL DISEASE TREATMENT OR PROPHYLAXIS

COMPOSITIONS AND METHODS FOR TREATING NEUROPSYCHIATRIC DISORDERS

USE OF SUBLINGUAL DEXMEDETOMIDINE FOR THE TREATMENT OF AGITATION

Peptide pharmaceuticals for treatment of NASH and other disorders

AMINOCARBONYLCARBAMATE COMPOUNDS

Compositions and Methods for Treating Aging and Age-Related Diseases and Symptoms

METHOD FOR TREATING RESPIRATORY VIRAL INFECTIONS COMPRISING ADMINISTRATION OF FATTY ACID COMPOSITIONS

Creatine, its derivatives, compositions and methods of use thereof

TREATMENT OF SCHIZOPHRENIA USING BETA-CARYOPHYLLENE AND CB2 RECEPTOR AGONISTS

TARGETING THE INNATE IMMUNE SYSTEM TO INDUCE LONG-TERM TOLERANCE AND TO RESOLVE MACROPHAGE ACCUMULATION IN ATHEROSCLEROSIS

Ionic Liquid-Based Nanoemulsion Formulation for the Efficient Delivery of Hydrophilic and Hydrophobic Therapeutic Agents

DELIVERY OF GENE EXPRESSION MODULATING AGENTS FOR THERAPY AGAINST CANCER AND VIRAL INFECTION

PH20 polypeptide variants, formulations and uses thereof

ENGINEERED VIRUS

IgG EPITOPE PEPTIDES THAT BIND RHEUMATOID FACTOR AND METHODS OF USE THEREOF

FIXED DOSING OF HER ANTIBODIES

ANTI-HUMAN TLR7 ANTIBODY

ANTI-ABCG2 ANTIBODIES AND USES THEREOF

Methods of treatment by targeting VCAM1 and MAEA

C-KIT antibodies and method for treating cancer with such

IL-23 Specific Antibodies for the Treatment of Systemic Sclerosis

NEUTRALIZING MONOCLONAL ANTIBODIES AGAINST COVID19

T CELL RECEPTORS WITH VGLL1 SPECIFICITY AND USES THEREOF

Silk Protein Fragment Compositions and Articles Manufactured Therefrom

Modified peptide fragments of CAV-1 protein and the use thereof in the treatment of fibrosis

Bile acid recycling inhibitors for treatment of hypercholemia and cholestatic liver disease

High affinity macrocyclic FKB51-inhibitors for treatment of psychiatric disorders

PYRROLO[2,1-F][1,2,4]TRIAZINE DERIVATIVE AND USE THEREOF

ALLOSTERIC EGFR INHIBITORS AND METHODS OF USE THEREOF

INHIBITORS OF CYSTEINE PROTEASES AND METHODS OF USE THEREOF

THERAPEUTIC COMPOUNDS FOR HIV VIRUS INFECTION

2-azaspiro[3.4]octane derivatives as M4 agonists

SOLID FORMS OF 2-(4-CHLOROPHENYL)-N-((2-(2,6-DIOXOPIPERIDIN-3-YL)-1-OXOISOINDOLIN-5-YL)METHYL)-2,2-DIFLUOROACETAMIDE, AND THEIR PHARMACEUTICAL COMPOSITIONS AND USES

Pyridine Inhibitors of Glucosylceramide Synthase and Therapeutic Methods Using the Same

NANOPARTICLES, IONIZING RADIATION AND INNOVATIVE THERAPEUTIC COMBINATIONS THEREOF

STATE-DEPENDENT PERIPHERAL NEUROMODULATION TO TREAT BLADDER DYSFUNCTION

MATERIALS AND METHODS FOR TREATMENT OF DISORDERS ASSOCIATED WITH THE IGHMBP2 GENE

Therapeutic use of engineered postbiotics comprising bacteriocins and/or endolysins

METHODS AND COMPOSITIONS FOR TREATING DIABETES

IL2 MUTEINS

COMPOSITION FOR PREVENTING OR TREATING INFLAMMATORY DISEASE COMPRISING HYDROLYSIS EXTRACT OF PULSATILLA KOREANA AND ANEMONE RADDEANA AS ACTIVE INGREDIENT

COMPOSITIONS AND METHODS FOR TREATING DEPRESSION

Methods and compositions for treating musculoskeletal diseases

SARS-COV-2-SPECIFIC T CELLS

Methods for preparing complex for enhancing immune response

COMPOSITIONS AND METHODS OF TREATING COVID-19 WITH HEPARIN OR OTHER NEGATIVELY CHARGED MOLECULES

Methods of Treating, Reducing the Incidence of, and/or Preventing Ischemic Events

Pharmaceutical Composition for Preventing or Treating Adverse Drug Reactions by Statin

COMPOSITION COMPRISING DILTIAZEM FOR TREATING A VIRAL INFECTION CAUSED BY SARS-COV-2 VIRUSES

CORONAVIRUS INFECTION THERAPEUTIC AGENT FORMED THROUGH COMBINATION OF PYRAZINE DERIVATIVE AND ANOTHER CORONAVIRUS INFECTION THERAPEUTIC DRUG

Substituted Alkynylene Compounds As Anticancer Agents

Bacterial nitric oxide synthase inhibitors

COMPOSITION FOR TOPICAL DERMATOLOGICAL DELIVERY

METHODS FOR TREATING ALZHEIMER'S DISEASE

COMPOSITIONS AND METHODS FOR TREATING SKIN AND NEUROPATHIC CONDITIONS AND DISORDERS

Treatment of circadian rhythm disorders

TRANS-CROCETIN COMPOSITIONS AND TREATMENT REGIMENS

PREVENTING AND TREATING HYPOGLYCEMIA

COMPOSITIONS AND METHODS FOR TREATING HEADACHES

Increasing Cancer Patient Survival Time by Administration of Dithio-Containing Compounds

METHOD FOR RAPID INFUSION OF CARMUSTINE

COMPOSITIONS AND METHODS OF TREATMENT WITH GLUTATHIONE

NANOSPHERE SIZE CONTROL BY VARYING THE RATIO OF COPOLYMER BLENDS

NON-PORCINE FORMULATIONS AND METHODS THEREOF

COMPOSITIONS FOR THE DELIVERY OF THERAPEUTIC AGENTS AND METHODS OF USE AND MAKING THEREOF

IMMUNOMODULATORY POLYNUCLEOTIDES AND USES THEREOF

MODIFIED ONCOLYTIC VIRUS

BISPECIFIC BINDING CONSTRUCTS

METHODS OF TREATING CANCERS USING PD-1 AXIS BINDING ANTAGONISTS AND TAXANES

RECOMBINANT MONOCLONAL ANTIBODIES AND CORRESPONDING ANTIGENS FOR COLON AND PANCREATIC CANCERS

CHIMERIC ANTIGEN RECEPTOR CAR OR CAR CONSTRUCT TARGETING BCMA AND CD19 AND APPLICATION THEREOF

Antibody Variants with Improved Pharmacokinetic Properties

Methods For Prevention Of Graft Rejection In Xenotransplantation

ANTI-MDR1 ANTIBODIES AND USES THEREOF

ANG2-BINDING MOLECULES

DNA ANTIBODY CONSTRUCTS FOR USE AGAINST HEPATITIS B VIRUS

Methods for treating cancer using soluble forms of PSGL-1 and fusion molecules thereof

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS

POLYNUCLEOTIDES COMPRISING AN ANTIGENIC PAYLOAD

Therapeutic compounds for HIV virus infection

Organic anion lithium ionic cocrystal compounds and compositions

MACROCYCLIC DIAMINE DERIVATIVES AS ENT INHIBITORS FOR THE TREATMENT OF CANCERS, AND COMBINATION THEREOF WITH ADENOSINE RECEPTOR ANTAGONISTS

PYRAZOLO[1,5-D][1,2,4]TRIAZINE-5(4H)-ACETAMIDES AS INHIBITORS OF THE NLRP3 INFLAMMASOME

MACROCYCLIC PAD4 INHIBITORS USEFUL AS IMMUNOSUPPRESSANT

Organic compounds

Spiros and Related Analogs for Inhibiting YAP/TAZ-TEAD

IMIDAZOLONYLQUINOLINES AND THE USE THEREOF AS ATM KINASE INHIBITORS

Naphthyridinone derivatives for the treatment of a disease or disorder

Compounds and methods for the enhanced degradation of targeted proteins

HETEROCYCLE AND GLUTARIMIDE SKELETON-BASED COMPOUND AND APPLICATIONS THEREOF

RSV INHIBITING 3-SUBSTITUTED QUINOLINE AND CINNOLINE DERIVATIVES

Notch Inhibitors and Uses Thereof

PHENETHYLAMINE COMPOUNDS SALTS, POLYMORPHIC FORMS AND METHODS OF USE THEREOF

Prodrugs of riluzole and their method of use

CANNABIGEROLIC ACID (CDGA) DERIVATIVES AND USES THEREOF

System and methods for treating cancer cells with alternating polarity magnetic fields

Controlled flow drug delivery implantable device

CARBON NANOTUBES AND COMPLEXES THEREOF FOR TREATING AND DETECTING OCULAR TUMORS

ANTI-PD-L1 ANTIBODIES

IMMUNE CHECKPOINT INHIBITOR COMBINATIONS

ORAL OCTREOTIDE ADMINISTERED IN COMBINATION WITH OTHER THERAPEUTIC AGENTS

HERBAL FORMULATION FOR THE PREVENTION AND MANAGEMENT OF TYPE-2 DIABETES MELLITUS AND ASSOCIATED MICROVASCULAR COMPLICATIONS

FECAL MATTER FOR TREATMENT OF CACHEXIA

FIBROBLAST THERAPY FOR PREVENTION AND REVERSION OF ANEURYSMS

IMMUNE CELLS DEFECTIVE FOR SUV39H1

DRUG THERAPY TO INHIBIT CHEMOTHERAPY-INDUCED ADVERSE EFFECTS AND RELATED PHARMACEUTICAL COMPOSITIONS, DIAGNOSTICS, SCREENING TECHNIQUES AND KITS

Treatment for coronavirus infection and associated cytokine toxicity

COMPOSITIONS AND METHODS OF USE THEREOF

METAL COMPOSITIONS AND METHODS OF USE THEREOF

COMPOSITIONS AND METHODS FOR TREATING VIRUS INFECTION

COMPOSITIONS AND METHODS FOR PREVENTING AND/OR TREATING MICROBIAL INFECTIONS

RIG-I AGONISTS AND METHODS USING SAME

TREATMENT OF ADVANCED METASTATIC CANCER

RESPONSE-GUIDED HCV THERAPY

INHIBITION OF NIDOVIRUSES THAT ENCODE NSP15

USE OF NICOTINAMIDE RIBOSIDE, NICOTINIC ACID RIBOSIDE, AND NICOTINAMIDE MONONUCLEOTIDE, REDUCED NICOTINYL COMPOUNDS, AND NICOTINOYL COMPOUND DERIVATIVES IN INFANT FORMULA FOR HEALTHY DEVELOPMENT

ADMINISTRATION OF AN ANTI-ACTIVIN-A COMPOUND TO A SUBJECT

COMBINATION THERAPY FOR CANCER TREATMENT

BETA-LACTAMASE INHIBITORS AND USES THEREOF

AZELASTINE AS ANTIVIRAL TREATMENT

COMBINATIONS OF ANTI-HER2 ANTIBODY-DRUG CONJUGATE AND CHEMOTHERAPEUTIC AGENTS, AND METHODS OF USE

COMPOSITION AND METHODS FOR TREATING RESPIRATORY DISEASES

METHODS FOR KILLING ANTIBIOTIC TOLERANT BACTERIA

Treating extrapyramidal syndrome using trapidil

Methods and Compositions for Treating Thyroid-Related Medical Conditions with Reduced Folates

COMPOSITIONS AND METHODS FOR SENSITIZING ACUTE MYELOID LEUKEMIAS TO CHEMOTHERAPY

COMBINATION COMPOSITIONS FOR IMMUNOTHERAPY

COMPOSITION AND METHOD FOR TREATMENT OF DEPRESSION AND PSYCHOSIS IN HUMANS

METHODS AND MATERIALS FOR ASSESSING AND TREATING CANCER

COMPOSITIONS AND METHODS FOR TREATING LEUKEMIA

Substituted aminoquinolones as DGKalpha inhibitors for immune activation

PPARy AGONISTS FOR TREATMENT OF KIDNEY DISEASE

METHODS FOR TREATING CANCER BY INHIBITING CARM1

PHARMACEUTICAL COMPOSITION CAPABLE OF INHIBITING REPLICATION OF CORONAVIRUS

COMPOSITIONS OF CANNABINOIDS AND METHODS OF USING SAME

Antineoplastic Combinations with m-TOR Inhibitor, Trastuzumab and/or HKI-272

USES OF ORNITHINE PHENYLACETATE FOR TREATING HYPERAMMONEMIA

Composition and method for muscle repair and regeneration

TOPICAL PHARMACEUTICAL COMPOSITION COMPRISING AT LEAST AMITRIPTYLINE, FOR THE TREATMENT OF PERIPHERAL NEUROPATHIC PAIN

Neutrophil suppression as preconditioning to increase oncolytic bacterial therapy

Use of atovaquone and proguanil for treatment of gastrointestinal diseases and inflammation

CHEMOEMBOLIC COMPOSITIONS AND METHODS OF TREATMENT USING THEM

LIPOSOME CONTAINING ETHYLENEDIAMINE TETRAACETIC ACID OR SALT THEREOF AND ERIBULIN OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF

SYSTEMS AND METHODS FOR DETECTING VIRAL DNA FROM SEQUENCING

MRNA treatment nanoparticles

CYTOTOXIC T-LYMPHOCYTE BINDING APTAMERS

BISPECIFIC PERSONALIZED APTAMERS

COMPOSITION FOR PREVENTING OR TREATING DISEASE CAUSED BY MUSCLE LOSS, COMPRISING AGENT INHIBITING PHF20

Compositions and Methods for Modifying Target RNAs

Nucleic acid molecules capable of modulating target gene expression and uses thereof

TAT-INDUCED CRISPR/ENDONUCLEASE-BASED GENE EDITING

NEOANTIGEN-INFORMED TUMOR-INFILTRATING LYMPHOCYTE CANCER IMMUNOTHERAPY

Human antibodies to the human glucagon receptor (HGCGR) and methods of use thereof to lower blood glucose or ketone levels

TOCILIZUMAB FOR THE TREATMENT OF VIRAL INFECTIONS

COMPOSITIONS AND METHODS FOR TREATING NONINFLAMMATORY PAIN IN SUBJECTS WITH RHEUMATOID ARTHRITIS

ANTI-IGF-I RECEPTOR ANTIBODY

THERAPEUTIC CD47 ANTIBODIES

CD96-BINDING AGENTS AS IMMUNOMODULATORS

Human Antibodies to GREM1

TAU BINDING COMPOUNDS

POLYPEPTIDES ENCODING ANTIBODIES BINDING TO SARS-COV-2 SPIKE PROTEIN

ANTIBODY THAT BINDS SPECIFICALLY TO THE SARS COV 2 SPIKE PROTEIN, AND METHODS FOR ITS MANUFACTURE

HUMAN IL-15 MUTANT AND USES THEREOF

ENGINEERED INTERLEUKIN-22 POLYPEPTIDES AND USES THEREOF

STAT3 INHIBITION FOR TREATMENT AND PREVENTION OF HUMAN CORONAVIRUS INFECTION

COMPOSITIONS AND METHODS OF MODULATING SHORT-CHAIN DEHYDROGENASE ACTIVITY

MORPHINAN ISOMERS AND THEIR STRUCTURAL MODIFICATIONS AS NMDAR ANTAGONISTS AND NEUROPLASTOGENS

PYRAZOLOPYRAZINES ACTING ON CANCERS VIA INHIBITION OF CDK12

CYP11A1 INHIBITORS

SMALL MOLECULE INHIBITORS OF CAV3.2 ACTIVITY AND USES THEREOF

N-(HETEROCYCLYL AND HETEROCYCLYLALKYL)-3-BENZYLPYRIDIN-2-AMINE DERIVATIVES AS SSTR4 AGONISTS

Heterocyclic GLP-1 agonists

NOVEL SOLUBLE EPOXIDE HYDROLASE INHIBITORS AND METHOD OF USE THEREOF

Condoms lubricated with antiviral lubricious compositions containing lambda-carrageenan

Charged Ion Channel Blockers and Methods for Use

NEURO-ATTENUATING KETAMINE AND NORKETAMINE COMPOUNDS, DERIVATIVES THEREOF, AND METHODS

Treating metastatic cancer and model systems for metastatic disease

AAV Vector for Disrupting Coagulation Factor-Related Gene on Liver Genome

NANOSYSTEMS AS SELECTIVE VEHICLES

Method of treating diseases of the kidney and urinary tract by administering a peptide-linked therapeutic agent

Immunologically Active Peptide-Biliverdin Conjugate, Preparation Method Therefor and Application Thereof

Anti-TIGIT Antibodies

DNABII VACCINES AND ANTIBODIES WITH ENHANCED ACTIVITY

COMBINATION THERAPY WITH NEOANTIGEN VACCINE

Methods for treating pulmonary disease using inter-alpha inhibitor proteins

DODECAFLUOROPENTANE EMULSION AS A STROKE AND ISCHEMIA THERAPY

ANTI-NET COMPOUNDS FOR TREATING AND PREVENTING FIBROSIS AND FOR FACILITATING WOUND HEALING

PLACENTAL ALKALINE PHOSPHATASE TO PROMOTE SCAR-FREE HEALING OF ACNE VULGARIS AND OTHER INFLAMMATORY SKIN LESIONS CAUSED BY MICROBIAL INFECTIONS

Pharmaceutical composition for cancer treatment comprising fusion protein including IL-2 protein and CD80 protein and anticancer drug

SINGLE-ARM ACTRIIA AND ACTRIIB HETEROMULTIMERS AND METHODS FOR TREATING PULMONARY HYPERTENSION

METHODS AND COMPOSITIONS RELATED TO THE TREATMENT OF NURR1- AND PPARy-MEDIATED CONDITIONS

METHODS OF TREATING NASH AND COMPOSITIONS THEREFORE

PURIFIED AMPHIPHILIC PEPTIDE COMPOSITIONS AND USES THEREOF

METHODS FOR REDUCING RISKS ASSOCIATED WITH HEART FAILURE AND FACTORS ASSOCIATED THEREWITH